retatrutide glp-1 gip glucagon triple agonist The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro Retatrutide for weight loss: Study

After eating, our cells take in glucose from the bloodstream and use it to fuel essential activities

and scientific advisory boards for Eli Lilly, Novo Nordisk, Amgen, Pfizer, Currax, Calibrate, Vida Health, Ilant Health, Mellicell, Sweetch, Doximity, GoodRx, Empros Pharma, Clearmind Medicine, and Apnimed.The other authors report no disclosures

It doesn't outperform injectables on raw weight loss numbers, but it removes a massive barrier for a large segment of the population

All strengths will be available from the manufacturer as the shortage has ended, but after April 22, 2025, compounding pharmacies will be only able to make custom doses